Newsletters
-
PD for Wed 31 Jan 2024
Wednesday | Jan 31 2024Cormack Review's first issues paper released, vaccination service fee rise, MedAdvisor shows strong growth, tonnes of single-use vapes seized, new CSL vaccine on NIP, and more.
-
PD for Tue 30 Jan 2024
Tuesday | Jan 30 2024CAPS rally cancelled, Cannatrek MoU signed, promising study results for Starpharma's Viraleze, call to update guidelines to include potassium-enriched salt, APP2024 early bird registration closing, and more.
-
PD for Mon 29 Jan 2024
Monday | Jan 29 2024Australia Day honours for exceptional service, APC 2024 Colloquium, Pre-Budget Submissions from CHP and RACGP, TGA alerts, and more.
-
PD for Thu 25 Jan 2024
Thursday | Jan 25 2024Success for full scope reforms, PSA and Audirie partnership, Sigma raises $223m in retail offer, feedback sought for UniSA accountability survey, and more.
-
PD for Wed 24 Jan 2024
Wednesday | Jan 24 2024Vic Inquiry into Women's Pain, Guild energy deal to start, APP2024 early bird closing, ACP's new CPD courses on anaemia, and more.
-
PD for Tue 23 Jan 2024
Tuesday | Jan 23 2024NAPSA Congress 2024 inspires future generation, NSW students eligible for subsidies, FDA's serious warning on Prolia, and more.
-
PD for Mon 22 Jan 2024
Monday | Jan 22 2024Call for more accessibility for RSV vaccine, NAPSA Wildcard winner, Victorian pharmacist disqualified, prenatal exposure to opioids study, and more.
-
PD for Fri 19 Jan 2024
Friday | Jan 19 2024Tas palliative care program launched, CAPS raises concerns over silence on 8CPA, nicotine advertising permission repealed, PSA 24 registration opens, and more.
-
PD for Thu 18 Jan 2024
Thursday | Jan 18 2024Prota raises millions to develop peanut allergy drug, first RSV vaccine approved for over 60s, Dementia Australia education campaign, Beauty and Wellness, and more.
-
PD for Wed 17 Jan 2024
Wednesday | Jan 17 2024Sale of Telstra Health portfolio, Sukin brand sold by BWX, self-testing of cervical screening grows, NSW Health measles alert, and more.